Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques

Giosuè Costa;Roberta Rocca;Angela Corona;Nicole Grandi;Federica Moraca;Isabella Romeo;Carmine Talarico;Maria Giovanna Gagliardi;Francesca Alessandra Ambrosio;Francesco Ortuso;Stefano Alcaro;Simona Distinto;Elias Maccioni;Enzo Tramontano;Anna Artese

2019-01-01

---

Abstract

In this work we report a parallel application of both docking- and shape-based virtual screening (VS) methods, followed by Molecular Dynamics simulations (MDs), for discovering new compounds able to inhibit the human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) RNA-dependent DNA polymerase activity. Specifically, we screened more than 143000 natural compounds commercially available in the ZINC database against the best five RT crystallographic models, taking into account the five approved NNRTIs as query compounds. As a result, 20 hit molecules were selected and tested on biochemical assays for the inhibition of the RNA dependent DNA polymerase RT function and, among them, an indoline pyrrolidine (hit1), an indonyl piperazine (hit2) and an indolyl indolinone (hit3) derivatives were identified as novel non-nucleoside RT inhibitors in the low micromolar range.